Biotech Late Stage Investors & VC Firms
90 firms in this list, with a median first check of $4.1M. 25 of them lead rounds. Generated from verified public data and updated continuously.
Pitango
Tel AvivPre-Seed–Late Stage
Ysios Capital
DenmarkSeries A–Late Stage
Apple Tree Venture Management Llc
New YorkPre-Seed–Late Stage
Octopus Ventures
LondonPre-Seed–Late Stage$125K
Medicxi
LondonPre-Seed–Late Stage
Illumina Ventures
Foster CityPre-Seed–Late Stage
Lightstone Ventures
Portola ValleyPre-Seed–Late Stage
Atlas Venture
CambridgeSeed–Late Stage
Artis Ventures
San FranciscoSeed–Late Stage
Abingworth
LondonPre-Seed–Late Stage$15M – $30M
US Venture Partners
Menlo ParkSeed–Late Stage
McKesson Ventures
San FranciscoSeed–Late Stage
Novartis Venture Fund
BaselPre-Seed–Late Stage$5M – $25M
aMoon
Ra'ananaSeed–Late Stage
Novo Holdings
CopenhagenPre-Seed–Late Stage
venBio Partners
San FranciscoSeed–Late Stage
Sanderling Ventures
San MateoLate Stage
RiverVest Venture Partners
St. LouisPre-Seed–Late Stage
Transform Capital Management
San FranciscoSeed–Late Stage
Celesta Capital
San MateoSeries A–Late Stage
California Technology Ventures
PasadenaSeed–Late Stage$250K – $2M
Osage University Partners
Pre-Seed–Late Stage$1M – $20M
Agent Capital
WalthamPre-Seed–Late Stage
S32
Palo AltoSeries A–Late Stage
Related lists
Late Stage Investors & VC Firms (1479)Biotech Investors & VC Firms (320)Biotech Seed Investors & VC Firms (255)Biotech Series A Investors & VC Firms (228)Biotech Pre-Seed Investors & VC Firms (153)Biotech Series B Investors & VC Firms (148)AI & Machine Learning Late Stage Investors & VC Firms (146)Healthtech Late Stage Investors & VC Firms (118)Biotech Growth Investors & VC Firms (104)Fintech Late Stage Investors & VC Firms (98)
Data sourced from public filings and firms' own websites — see our methodology.